AttorneyOne.com Informs: You Can Still File a Claim and Receive Compensation for Fen Phen Side Effects
People who tried Fen Phen in the past might just now experience symptoms related to heart valve damage. Fen Phen is a diet pill popular in the 1990’s. In July 1997 the Mayo Clinic and Mayo Foundation reported 24 cases of a rare heart valve disease among women who took Fen Phen. On September 15, 1997, the FDA ordered Fen Phen, taken on the shelves and banned the sale. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal council so anyone can easily and inexpensively deal with cases of Fen Phen side effects. http://www.attorneyone.com/fen-phen-lawsuits/ (http://www.attorneyone.com/fen-phen-lawsuits/)
(PRWeb January 27, 2012)
Read the full story at
more info…
Medical therapy is best for atherosclerotic renal artery stenosis: Arguments for.
Indian J Nephrol. 2012 Jan; 22(1): 1-4
Annigeri RA
Atherosclerotic renal artery stenosis (ARAS) is a common condition that causes hypertension and reduction in the glomerular filtration rate and is an independent risk factor for death. Despite high technical success, the clinical benefit of renal artery (RA) angioplasty with stenting in ARAS remains doubtful. The published randomized clinical trials provide no support for the notion that renal angioplasty with stenting significantly improves blood pressure, preserves renal function, or reduces episodes of congestive heart failure in patients with ARAS. RA stenting is associated with procedure-related morbidity and mortality. Agents to block the renin-angiotensin-aldosterone system improve outcome and should be a part of a multifaceted medical regimen in ARAS. Medical therapy effectively controls atherosclerotic renovascular disease at all levels of vasculature and hence is the best therapy for ARAS.
more info…
Business Wire - Cell>Point Executes Brazil License with Radiopharmacus for Cancer and Heart Disease Molecular Imaging Drug, EC-G
January 24, 2012 — Cellpoint has completed a Brazil license for its drug candidate, EC-G. EC-G is now in clinical trials for accurate, accessible diagnosis of lung…
Tue, 24 Jan 2012 00:00:00 PST
more info…
Reverse Heart Disease without Prescribing Cholesterol Lowering Drugs - San Francisco Chronicle (press release)
![]()
Reverse Heart Disease without Prescribing Cholesterol Lowering Drugs
San Francisco Chronicle (press release)
The Heart Fit Clinic sides with Dr. Rita Redberg, in a recent debate with Dr. Roger Blumenthal regarding prescribing statins (cholesterol lowering drugs) for patient with who have not had a heart attack. Heart disease continues to be the leading cause …
and more »
Thu, 26 Jan 2012 09:11:39 GMT
more info…
@DietCokeUS Support #Heart #Health http://t.co/RH5DaV9O R U kidding me? http://t.co/FgGqVPgJ Avoid soft drinks regular or diet!!
@DietCokeUS Support #Heart #Health http://t.co/RH5DaV9O R U kidding me? http://t.co/FgGqVPgJ Avoid soft drinks regular or diet!!
JoDiffenbaugh@twitter.com (Jo Diffenbaugh)
Fri, 27 Jan 2012 09:41:15 +0000
more info…
